Idiopathic pulmonary fibrosis in Brazil: challenges for epidemiological characterization and management. [PDF]
J Bras Pneumol, 2017 Baldi BG.
europepmc +1 more source
Respiratory system parameters in children with low severity cystic fibrosis: is there early involvement in relation to healthy peers? [PDF]
Rev Paul Pediatr, 2023 Ducati GC +3 more
europepmc +1 more source
Mortality from idiopathic pulmonary fibrosis: a temporal trend analysis in Brazil, 1979-2014. [PDF]
J Bras Pneumol, 2017 Algranti E +4 more
europepmc +1 more source
Impact of COVID-19 social distancing recommendations on pulmonary function, nutritional status, and morbidity in patients with cystic fibrosis. [PDF]
Rev Paul Pediatr, 2023 Bagatini MA +4 more
europepmc +1 more source
Estimation of care costs for individuals with cystic fibrosis at a referral center: cohort study, Salvador, 2005-2022. [PDF]
Epidemiol Serv SaudeCosta JCB, Sorte NCAB, D'Souza EL.
europepmc +1 more source
Six-minute walk distance and survival time in patients with idiopathic pulmonary fibrosis in Brazil. [PDF]
J Bras Pneumol, 2018 Mancuzo EV, Soares MR, Pereira CAC.
europepmc +1 more source
Selvester QRS Score is a Predictor of Mortality in Heart Failure with Preserved Ejection Fraction. [PDF]
Arq Bras Cardiol, 2023 Sivri F +8 more
europepmc +1 more source
Mecanismos fisiopatológicos da fibrose pulmonar induzida por fármacos
, 2018 The lungs are a target for a variety of possible toxic substances because of their large contact surface, and the drugs can induce lesions through direct, dose-dependent cytotoxic or immuno-mediated mechanisms, described by Gell and Coombs, for the most part mediated by T cells, giving rise to drug-induced interstitial lung diseases. Pulmonary fibrosis
openaire +1 more source
Constrictive Pericarditis with Caseous Necrosis: A Rare and Underrecognized Presentation. [PDF]
Arq Bras CardiolWolf PJW +12 more
europepmc +1 more source